Great to present my work @ASCEPTconf Thanks to @laurentmay @SimonFoster_PhD @pjwhite71 @buisanthai @ngocanhddb

Final day @WCP2023. It was massive. Congratulations to Felix for winning ECR Oral Prize. See you in Melbourne, Australia @WCP2026 @MIPS_DDB @BritPharmSoc @ASCEPTanz

Day 04. I presented my poster at the 19 th World Pharmacology Congress. Thanks to @laurentmay @SimonFoster_PhD @pjwhite71 @buisanthai @WCP2023 @WCP2026 @BritPharmSoc @IUPHAR @MIPS_Australia @MIPS_DDB #CardioMetabolicTPA

Day 03 @WCP2023 Glasgow, Scotland. @WCP2026 hapening live in Melbourne, Australia. Come grab a cup of coffee ☕️ at the @WCP2026 booth. @ASCEPTanz @ASCEPTconf

Here We Go! Day 1: World Congress of Pharmacology. @WCP2023 @ASCEPTconf @WCP2026 @MIPS_Australia

Joel Coffie @JoeWake7 @MIPS_DDB explain how, like water, cardiac fibroblasts can be both helpful and harmful. He is researching new treatments that can protect the heart from fibroblasts in heart failure ❤️🫀

I had a great opportunity to present my work as one of the 6 finalists in the keenly contested Garth McQueen Students’ Prize. A big thanks to @ASCEPTanz and the biggest appreciation to my supervisors @laurentmay @SimonFoster_PhD @pjwhite71.Thanks to @buisanthai and the ENC team.

👏👏Congratulations @ngocanhddb on your fabulous @Certara New Investigator Award presentation #APSA_ASCEPT2022 @ASCEPTanz 🤩

Super honoured to receive the 2022 Certara New Investigator Award. I couldn't make it without my great supervisors @laurentmay, Prof. Arthur Christopoulos, many past and present members of the Cardiac GPCR Biology laboratory, and our collaborators 🥰

#TPATuesday announces the 4th Immunometabolism Symposium will be hosted by #CardioMetabTPA and MIPS on the 15th July. Please register and submit your abstract by 1st July at forms.gle/zSgPrBgqV9anqrWK9

#TPATuesday #CardioMetabolicTPA Dr @ling_yeong employs preclinical models to develop drugs that safeguard the heart against damages after ischemic heart disease treatment 👉 monash.edu/pharm/research/ar…

@BuiSanThai1 employs preclinical models to assess the effectiveness of our novel therapeutic approaches to stimulate cardioprotection in at-risk populations. Watch this space for her exciting research findings! @pjwhite71 @DanaHut57968913 @ngocanhddb monash.edu/pharm/research/ar…

#TPATuesday #CardioMetabolicTPA @ngocanhddb uses molecular & computational pharmacology to understand drug-receptor interactions, a crucial step towards developing better treatment options for cardiovascular disease 👉monash.edu/pharm/research/ar…